Intel to use 'big data' to battle Parkinson's disease

August 13, 2014
Intel headquarters on January 16, 2014 in Santa Clara, California

US computing giant Intel announced Wednesday it was joining an effort to battle Parkinson's disease with new big data and wearable technologies to improve research and treatment.

Intel said it would work with the Michael J. Fox Foundation for Parkinson's Research—created by the "Back to the Future" Canadian-American actor—on the effort to fight the neurodegenerative brain disease second only to Alzheimer's in worldwide prevalence.

The research will use "a new big data analytics platform that detects patterns in participant data collected from wearable technologies used to monitor symptoms," an Intel statement said.

"This effort is an important step in enabling researchers and physicians to measure progression of the disease and to speed progress toward breakthroughs in ."

The statement added that by collecting and analyzing data from thousands of individuals, such as slowness of movement, tremor and sleep quality, researchers can get a better picture of the progression of the disease.

The research will use wearables that "can unobtrusively gather and transmit objective, experiential data in real time, 24 hours a day, seven days a week," according to the statement.

"Nearly 200 years after Parkinson's disease was first described by Dr James Parkinson in 1817, we are still subjectively measuring Parkinson's disease largely the same way doctors did then," said Todd Sherer, chief executive of the foundation.

"Data science and hold the potential to transform our ability to capture and objectively measure patients' actual experience of disease, with unprecedented implications for Parkinson's drug development, diagnosis and treatment."

Explore further: Blood biomarker could mark severe cognitive decline, quicker progression among Parkinson's patients

Related Stories

Blood biomarker could mark severe cognitive decline, quicker progression among Parkinson's patients

September 18, 2013
A genetic mutation, known as GBA, that leads to early onset of Parkinson's disease and severe cognitive impairment (in about 4 to 7 percent of all patients with the disease) also alters how specific lipids, ceramides and ...

Anti-inflammatory drug can prevent neuron loss in Parkinson's model

July 25, 2014
An experimental anti-inflammatory drug can protect vulnerable neurons and reduce motor deficits in a rat model of Parkinson's disease, researchers at Emory University School of Medicine have shown.

First clinical data of therapeutic Parkinson's disease vaccine encourages continued development

August 1, 2014
AFFiRiS AG announced today at a press conference in New York results of AFF008, a Phase I clinical trial of PD01A, a vaccine against Parkinson's disease. PD01A is the first therapy against the protein alpha-synuclein, a promising ...

Researchers investigating genetics of Parkinson's disease

March 11, 2014
(Medical Xpress)—Researchers at Emory University School of Medicine will study individuals with genetic mutations associated with Parkinson's disease (PD) as part of the Parkinson's Progression Markers Initiative (PPMI), ...

Depression a key factor in health of Parkinson's patients: study

November 28, 2012
(HealthDay)—Depression is the most important determinant of the health status of people with Parkinson's disease, according to early findings from a large study of Parkinson's patients.

Intel buys fitness-tracking band maker Basis (Update)

March 25, 2014
Intel announced it has bought fitness-tracking band maker Basis Science as part of a move into the hot wearable computing market.

Recommended for you

Parkinson's is partly an autoimmune disease, study finds

June 21, 2017
Researchers have found the first direct evidence that autoimmunity—in which the immune system attacks the body's own tissues—plays a role in Parkinson's disease, the neurodegenerative movement disorder. The findings raise ...

Predicting cognitive deficits in people with Parkinson's disease

June 20, 2017
Parkinson's disease (PD) is commonly thought of as a movement disorder, but after years of living with PD approximately twenty five percent of patients also experience deficits in cognition that impair function. A newly developed ...

Pre-clinical study suggests Parkinson's could start in gut endocrine cells

June 15, 2017
Recent research on Parkinson's disease has focused on the gut-brain connection, examining patients' gut bacteria, and even how severing the vagus nerve connecting the stomach and brain might protect some people from the debilitating ...

Hi-res view of protein complex shows how it breaks up protein tangles

June 15, 2017
Misfolded proteins are the culprits behind amyotrophic lateral sclerosis (ALS), Alzheimer's disease, Parkinson's disease, and other neurodegenerative brain disorders. These distorted proteins are unable to perform their normal ...

CRISPR tech leads to new screening tool for Parkinson's disease

June 5, 2017
A team of researchers at the University of Central Florida is using breakthrough gene-editing technology to develop a new screening tool for Parkinson's disease, a debilitating degenerative disorder of the nervous system. ...

Infection with seasonal flu may increase risk of developing Parkinson's disease

May 30, 2017
Most cases of Parkinson's have no known cause, and researchers continue to debate and study possible factors that may contribute to the disease. Research reported in the journal npj Parkinson's Disease suggests that a certain ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.